Beacon Pointe Advisors, LLC Novartis Ag Transaction History

Beacon Pointe Advisors, LLC

  • $8.76 Billion
  • Q1 2025

A detailed history of Beacon Pointe Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 58,467 shares of NVS stock, worth $6.79 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
58,467
Previous 43,841 33.36%
Holding current value
$6.79 Million
Previous $4.27 Million 52.77%
% of portfolio
0.07%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$97.14 - $115.57 $1.42 Million - $1.69 Million
14,626 Added 33.36%
58,467 $6.52 Million
Q4 2024

Feb 14, 2025
SELL
$96.78 - $117.18 $398,443 - $482,430
-4,117 Reduced 8.58%
43,841 $4.27 Million
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $215,974 - $246,011
2,035 Added 4.43%
47,958 $5.52 Million
Q2 2024

Aug 12, 2024
BUY
$92.57 - $107.37 $111,917 - $129,810
1,209 Added 2.7%
45,923 $4.89 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $770,257 - $876,979
8,085 Added 22.07%
44,714 $4.33 Million
Q4 2023

Feb 08, 2024
BUY
$92.27 - $101.54 $397,130 - $437,028
4,304 Added 13.31%
36,629 $3.7 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $2.01 Million - $2.23 Million
21,231 Added 191.37%
32,325 $3.29 Million
Q2 2023

Aug 11, 2023
BUY
$92.52 - $104.91 $189,943 - $215,380
2,053 Added 22.71%
11,094 $1.12 Million
Q1 2023

May 12, 2023
SELL
$80.03 - $92.81 $466,975 - $541,546
-5,835 Reduced 39.22%
9,041 $831,000
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $9,897 - $12,120
-131 Reduced 0.87%
14,876 $1.35 Million
Q3 2022

Nov 09, 2022
SELL
$74.61 - $87.26 $203,610 - $238,132
-2,729 Reduced 15.39%
15,007 $1.14 Million
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $1.17 Million - $1.36 Million
-14,535 Reduced 45.04%
17,736 $1.5 Million
Q1 2022

May 17, 2022
BUY
$80.11 - $90.62 $1.57 Million - $1.77 Million
19,561 Added 153.9%
32,271 $2.83 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $52,044 - $57,548
-653 Reduced 4.89%
12,710 $1.11 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $65,751 - $76,492
-804 Reduced 5.68%
13,363 $1.09 Million
Q2 2021

Aug 17, 2021
BUY
$85.24 - $94.15 $647,483 - $715,163
7,596 Added 115.6%
14,167 $1.29 Million
Q1 2021

May 18, 2021
SELL
$83.5 - $98.47 $539,577 - $636,313
-6,462 Reduced 49.58%
6,571 $563,000
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $147,474 - $178,378
1,889 Added 16.95%
13,033 $1.23 Million
Q3 2020

Nov 16, 2020
SELL
$82.14 - $91.0 $119,513 - $132,405
-1,455 Reduced 11.55%
11,144 $969,000
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $207,342 - $233,398
2,562 Added 25.53%
12,599 $1.1 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $709,314 - $993,763
10,037 New
10,037 $826,000

Others Institutions Holding NVS

# of Institutions
1,544
Shares Held
141M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $250B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email